AbCellera Biologics (ABCL) Change in Acquisitions & Divestments: 2021-2025
Historic Change in Acquisitions & Divestments for AbCellera Biologics (ABCL) over the last 4 years, with Sep 2025 value amounting to $83.1 million.
- AbCellera Biologics' Change in Acquisitions & Divestments fell 57.73% to $83.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $588.4 million, marking a year-over-year decrease of 41.39%. This contributed to the annual value of $937.9 million for FY2024, which is 2.96% up from last year.
- Per AbCellera Biologics' latest filing, its Change in Acquisitions & Divestments stood at $83.1 million for Q3 2025, which was down 26.73% from $113.4 million recorded in Q2 2025.
- AbCellera Biologics' Change in Acquisitions & Divestments' 5-year high stood at $306.5 million during Q1 2024, with a 5-year trough of $18.1 million in Q4 2021.
- Its 3-year average for Change in Acquisitions & Divestments is $203.2 million, with a median of $201.9 million in 2024.
- In the last 5 years, AbCellera Biologics' Change in Acquisitions & Divestments soared by 410.99% in 2022 and then crashed by 57.73% in 2025.
- Quarterly analysis of 5 years shows AbCellera Biologics' Change in Acquisitions & Divestments stood at $18.1 million in 2021, then spiked by 410.99% to $92.4 million in 2022, then skyrocketed by 190.09% to $268.0 million in 2023, then decreased by 24.67% to $201.9 million in 2024, then tumbled by 57.73% to $83.1 million in 2025.
- Its Change in Acquisitions & Divestments was $83.1 million in Q3 2025, compared to $113.4 million in Q2 2025 and $190.0 million in Q1 2025.